Nick is the current Chair of the TOGA Board and has previously served on the Boards of Northern Cancer Institute and COSA, where he was President from 2019-2020.
His training and research background includes new drug development, biomarker research, clinical trials, including TOGA’s ASPiRATION study, and clinical practice guidelines development.
Nick has served on the leadership committees of numerous national/international collaborative group trials in lung cancer, mesothelioma and gastrointestinal cancers. He was involved in the development of Australian clinical practice guidelines in lung cancer and mesothelioma. He has served as faculty of the International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer, its Mesothelioma task force and is current co-chair of the IASLC Continuing Medical Education Committee; and is a faculty member of the MOGA/ASCO/ACCR Australia and Asia Pacific Clinical Oncology Research Development Workshop (ACORD).
